Differential effects of endogenous and synthetic cannabinoids on α7-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 3, 2004, Pages 1152-1160

  Oz, Murat ^a   Zhang, Li ^c   Ravindran, Arippa ^c   Morales, Marisela ^b   Lupica, Carl R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Behavioral Neurobiology Branch   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; DRONABINOL; ETHANOLAMINE; LIGAND; METHANANDAMIDE; NICOTINIC RECEPTOR; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONTROLLED STUDY; ELECTRODE; IC 50; MEMBRANE POTENTIAL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; VOLTAGE CLAMP; XENOPUS;

ANALGESICS, NON-NARCOTIC; ANIMALS; CANNABINOIDS; ENDOCANNABINOIDS; OOCYTES; RECEPTORS, CANNABINOID; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL; XENOPUS LAEVIS;

EID: 4243057253     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.067751     Document Type: Article

References (53)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, and Makriyannis A (1994) (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37:1889-1893.
2. Arias HR (1998) Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules. J Neurosci Res 52:369-379.
3. Barann M, Molderings G, Bruss M, Bonisch H, Urban BW, and Gothert M (2002) Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol 137:589-596.
4. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, and Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO (Eur Mol Biol Organ) J 20:7033-7040.
5. Damaj IM, Meyer EM, and Martin BR (2000) The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 39:2785-2791.
6. Dani JA (2001) Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 49:166-174.
7. Dascal N (1987) The use of Xenopus oocytes for the study of ion channels. CRC Crit Rev Biochem 22:317-387.
8. Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, and Bisogno T (2002) Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 66:377-391.
9. Du C and Role LW (2001) Differential modulation of nicotinic acetylcholine receptor subtypes and synaptic transmission in chick sympathetic ganglia by PGE2. J Neurophysiol 85:2498-2508.
10. Eisele JL, Bertrand S, Galzi JL, Devillers-Thiery A, Changeux JP, and Bertrand D (1993) Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature (Lond) 366:479-483.
11. Freund TF, Katona I, and Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066.
12. Girod R, Barazangi N, McGehee D, and Role L (2000) Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39:2715-2725.
13. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, and Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 4:358-363.
14. Godlewski G, Gothert M, and Malinowska B (2003) Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT(3) receptor-mediated von Bezold-Jarisch reflex. Br J Pharmacol 138:767-774.
15. Henry DJ and Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neuroscience Lett 186:91-94.
16. Howlett AC and Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108:53-70.
17. Jackson MB and Yakel JL (1995) The 5-HT3 receptor channel. Annu Rev Physiol 57:447-468.
18. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, and Wells G (1996) Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 109: 125-137.
19. Maejima T, Hashimoto K, Yoshida T, Aiba A, and Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-475.
20. Maingret F, Patel AJ, Lazdunski M, and Honore E (2001) The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO (Eur Mol Biol Organ) J 20:47-54.
21. McGehee DS, Heath MJS, Gelber S, Devay P, and Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Nature (Lond) 269:1692-1696.
22. Mombouli JV, Schaeffer G, Holzmann S, Kostner GM, and Graier WF (1999) Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells. Br J Pharmacol 126:1593-1600.
23. Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, Singh G, and Lees G (2003) Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 978:194-204.
24. Nishizaki T, Matsuoka T, Nomura T, and Sumikawa K (1998) Modulation of ACh receptor currents by arachidonic acid. Mol Brain Res 57:173-179.
25. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, and Kano M (2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18:109-116.
26. Orr-Urteger A, Broide RS, Kasten MR, Dang H, Dani JA, Beaudet AL, and Patrick JW (2000) Mice homozygous for the L250T mutation in the alpha 7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J Neurochem 74:2154-2166.
27. Oz M, Ravindran R, Zhang L, and Morales M (2003) Endogenous cannabinoid, anandamide inhibits neuronal nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 306:1003-1010.
28. 1A receptor coexpressed in Xenopus oocytes. Mol Pharmacol 54:1106-1112.
29. Oz M, Tchugunova Y, and Dunn SMJ (2000) Endogenous cannabinoid anandamide directly inhibits voltage-dependent calcium fluxes in rabbit T-tubule membrane preparations. Eur J Pharmacol 404:13-20.
30. 3 receptor-mediated responses in Xenopus oocytes. Synapse 46:150-156.
31. Oz M, Zhang L, and Spivak CE (2002b) Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. Arch Biochem Biophys 404:293-301.
32. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129-180.
33. Picciotto MR, Caldareno BJ, Brunzell DH, Zachariou V, Stevens TR, and King SL (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92:89-108.
34. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
35. Piomelli D, Beltramo M, Giuffrida A, and Stella N (1998) Endogenous cannabinoid signaling. Neurobiol Dis 5:462-473.
36. Poling JS, Rogawski MA, Salem N, and Vicini S (1996) Anandamide, an endogenous cannabinoid inhibits Shaker-related voltage-gated K+ channels. Neuropharmacology 35:983-991.
37. Pryor GT, Larsen FF, Husain S, and Braude MC (1978) Interactions of delta-9-tetrahydrocannabinol with amphetamine, cocaine and nicotine in rats. Pharmacol Biochem Behav 8:295-318.
38. Reeves DC and Lummis SC (2002) The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol Membr Biol 19:11-26.
39. 7 expressed in Xenopus oocytes. Biophys J 65:2614-2621.
40. Schmitt BM and Koepsell H (2002) An improved method for real-time monitoring of membrane capacitance in Xenopus laevis oocytes. Biophys J 82:1345-1357.
41. Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, and Patrick JW (1993) Molecular cloning, functional properties and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604.
42. Stella N and Piomelli D (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425:189-196.
43. Sugiura T, Kobayashi Y, Oka S, and Waku K (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 66:173-192.
44. Sugiura T, Kodaka T, Kondo S, Tonegawa T, Nakane S, Kishimoto S, Yamashita A, and Waku K (1996) 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 229:58-64.
45. 2 in chick sympathetic ganglion neurons. J Neurophysiol 79:870-878.
46. Valjent E, Mitchell JM, Besson MJ, Caboche J, and Maldonado R (2002) Behavioral and biochemical evidence for interactions between [delta]9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564-578.
47. Van den Bossche I and Vanheel B (2000) Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Br J Pharmacol 131:85-93.
48. Varma N, Carlson GC, Ledent C, and Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21: RC188.
49. Venance L, Piomelli D, Glowinski J, and Giaume C (1995) Inhibition by anandamide of gap junctions and intercellular calcium signaling in striatal astrocytes. Nature (Lond) 376:590-594.
50. Vijayaraghavan S, Huang B, Blumenthal EM, and Berg DK (1995) Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons. J Neurosci 15:3679-3687.
51. Wilson RI and Nicoll RA (2002) Endocannabinoid signaling in the brain. Science (Wash DC) 296:678-682.
52. Yu D, Zhang L, Eisele JL, Bertrand D, Changeux JP, and Weight FF (1996) Ethanol inhibition of nicotinic acetylcholine type α7 receptors involves the amino-terminal domain of the receptor. Mol Pharmacol 50:1010-1016.
53. 3 receptors expressed in Xenopus Oocytes. Br J Pharmacol 120:353-355.